Reducing Immunogenicity of Pegloticase With Concomitant Use of Mycophenolate Mofetil in Patients With Refractory Gout: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial is a research paper published in Arthritis & Rheumatology (2021). On theSindex it has a DataRank of 2.1. It has been cited 56 times, with 44 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.606
From this paper's citation signal
Citation Network Contribution
1.5
From 36 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 44 citers.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: R21AR071684
NIAMS NIH HHS
Grant: K24 AR063120
MeSH Terms